Search Results - "Heim, Lisanne"
-
1
Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non-Small Cell Lung Carcinoma
Published in Cancer research (Chicago, Ill.) (01-11-2017)“…The lipid hydrolase enzyme acid sphingomyelinase (ASM) is required for the conversion of the lipid cell membrane component sphingomyelin into ceramide. In…”
Get full text
Journal Article -
2
NFATc1 Promotes Antitumoral Effector Functions and Memory CD8 + T-cell Differentiation during Non-Small Cell Lung Cancer Development
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Nuclear factor of activated T cells 1 (NFATc1) is a transcription factor activated by T-cell receptor (TCR) and Ca signaling that affects T-cell activation and…”
Get full text
Journal Article -
3
Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer
Published in British journal of cancer (30-04-2019)“…Background The immunosuppressive role of the cytokine IL-35 in patients with non-small cell lung cancer (NSCLC) is poorly understood. In this study, we…”
Get full text
Journal Article -
4
IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer
Published in Frontiers in immunology (20-04-2022)“…Although lung cancer is the leading cause of cancer deaths worldwide, the mechanisms how lung cancer cells evade the immune system remain incompletely…”
Get full text
Journal Article -
5
ID: 175: The role of STAT3 (Signal Transducer and Activator of Transcription protein-3) in non-small cell lung cancer (NSCLC)
Published in Cytokine (Philadelphia, Pa.) (01-11-2015)“…STAT3 is a transcription factor that is activated downstream of several cytokines and growth factors by phosphorylation. It regulates the expression of genes…”
Get full text
Journal Article -
6
-
7
Interleukin-10-regulated tumour tolerance in non-small cell lung cancer
Published in British journal of cancer (21-11-2017)“…Background: Lung cancer is the most life-threatening cancer type worldwide. Treatment options include surgery, radio- and chemotherapy, as well as the use of…”
Get full text
Journal Article -
8
The role of STAT3 (signal transducer and activator of transcription 3) in non-small cell lung cancer (NSCLC)
Published in The Journal of immunology (1950) (01-05-2016)“…Non-small cell lung cancer (NSCLC) is associated with high mortality worldwide underlining the need for novel therapeutic approaches. Signal transducer and…”
Get full text
Journal Article -
9
The role of Signal Transducer and Activator of Transcription protein 5 (STAT5) in non-small cell lung cancer (NSCLC)
Published in The Journal of immunology (1950) (01-05-2016)“…Signal Transducer and Activator of Transcription protein 5 (STAT5a/b) belongs to a family of T cell transcription factors. The different isoforms of STAT5 are…”
Get full text
Journal Article -
10
STAT1 deficiency supports PD-1/PD-L1 signaling resulting in dysfunctional TNFα mediated immune responses in a model of NSCLC
Published in Oncotarget (14-12-2018)“…In this study we described that Signal Transducer and Activator of Transcription 1 (STAT1) is a key point regulator of PD-1 in tumour infiltrating lymphocytes…”
Get full text
Journal Article -
11
FAM13A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survival
Published in Oncoimmunology (01-01-2017)“…Genome-wide association studies (GWAS) associated Family with sequence similarity 13, member A (FAM13A) with non-small cell lung cancer (NSCLC) occurrence…”
Get full text
Journal Article